Skip to main content
. 2015 Oct 21;1:15018. doi: 10.1038/npjbcancer.2015.18

Figure 2.

Figure 2

Kaplan–Meier curves showing the survival of breast cancer patients when they initially have no evidence of metastasis to when they progress through their metastatic disease. (a) Comparison of ER+/HER2−, ER−/HER2−, and HER2+ patients, (b) patients with a solitary first metastatic site at bone, chest wall, liver, or brain, and (c) subsets of patients with different numbers of first relapse metastases.